United States securities and exchange commission logo





                             November 29, 2021

       Bradley L. Radoff
       Director
       The Radoff Family Foundation et al.
       2727 Kirby Drive
       Unit 29L
       Houston, TX 77098

                                                        Re: Enzo Biochem, Inc.
                                                            Preliminary Proxy
Statement on Schedule 14A
                                                            Filed November 19,
2021 by The Radoff Family Foundation; Bradley L.
                                                            Radoff; and Lorrie
A. Carr
                                                            File No. 001-09974

       Dear Mr. Radoff:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

               Please respond to these comments by providing the requested
information or advise us as
       soon as possible when you will respond. If you do not believe our
comments apply to your facts
       and circumstances, please tell us why in your response.

                                                        After reviewing your
response to these comments, we may have additional comments.

       Preliminary Proxy Statement on Schedule 14A

       Reasons for the Solicitation, page 4

   1.                                                   You must avoid issuing
statements that directly or indirectly impugn the character,
                                                        integrity or personal
reputation or make charges of illegal, improper or immoral conduct
                                                        without factual
foundation. Provide us supplementally, or disclose, the factual foundation
                                                        for the following
statements. In this regard, note that the factual foundation for such
                                                        assertion must be
reasonable. Refer to Rule 14a-9.

                                                              "We are also one
of several sizable shareholders with significant concerns regarding
                                                            Enzo   s imperial
corporate governance..."
                                                              "We have
concluded that the root cause of shareholder suffering is the seemingly
                                                            unchecked influence
and power of Dr. Elazar Rabbani...While all of the Company   s
 Bradley L. Radoff
The Radoff Family Foundation et al.
November 29, 2021
Page 2
              directors other than Dr. Rabbani are purportedly    independent
 based on the rules of
              the New York Stock Exchange, we fear that they are merely
'independent' in name
              only. These directors appear either completely beholden to Dr.
Rabbani or utterly
              oblivious to the unprecedented shareholder opposition to his
continued leadership."
                "It is increasingly clear to us that the current Board has
chosen to pull the wool over
              shareholders    eyes in an attempt to continue to allow Dr.
Rabbani to essentially run
              roughshod over the Company."
2.       Explain how your director nominees would be able to effect the changes
you advocate for
         (e.g., "better governance" and "superior value creation").
Incorporation by Reference, page 18

3.       Please advise us if the participants anticipate distributing their
proxy statement before the
         registrant distributes its proxy statement. Given that the planned
reliance on Rule 14a-
         5(c) is impermissible at any time before the registrant distributes
its proxy statement, the
         participants will accept all legal risk in connection with
distributing the initial definitive
         proxy statement without all required disclosures. Please confirm the
participants
         understand their obligation to subsequently provide any omitted
information in a
         supplement in order to mitigate that risk to the extent it arises in
the context of this
         solicitation.
4.       Note that reliance on Rule 14a-5(c) does not    incorporate    the
information referenced into
         the participants    proxy statement. "Incorporation by reference    is
explicitly governed by
         Note D to Schedule 14A codified at Rule 14a-101. That note provides
that    [i]nformation
         may be incorporated by reference only in the manner and to the extent
specifically
         permitted in the items of this schedule.    Please revise the header
to remove the
         implication that participants relying upon Rule 14a-5(c) incorporate
information from a
         registrant   s proxy statement into their own.
        We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

         Please direct any questions to Joshua Shainess at (202) 551-7951.



FirstName LastNameBradley L. Radoff                             Sincerely,
Comapany NameThe Radoff Family Foundation et al.
                                                                Division of
Corporation Finance
November 29, 2021 Page 2                                        Office of
Mergers & Acquisitions
FirstName LastName